ConductScience.org, home

Disease · MONDO_0850098

oligoasthenoteratozoospermia

6 sourcesdiseases-2026-09-18-0.1.0

Download JSON
Cite this record

ConductScience Library. oligoasthenoteratozoospermia. Diseases, record MONDO_0850098. Release diseases-2026-09-18-0.1.0, 18 Sept 2026. https://conductscience.org/library/diseases/MONDO_0850098

On this page

Disease

Names and IDs as Open Targets gives them. Its IDs in MeSH, Orphanet, the Disease Ontology and the NCI Thesaurus are those Open Targets states for it.

Name
oligoasthenoteratozoospermia
Open Targets
Open Targets ID
MONDO_0850098
Open Targets
Disease Ontology
DOID:0070311
Disease Ontology
Highest stage of its drugs
Phase 2, for 2 of its 14 drugs, from ClinicalTrials.gov
Open Targets

Drugs14

The drugs Open Targets' clinical reports study for the disease, the highest stage first, then the most trial reports. The stage is Open Targets', the highest any of its sources reports for the pair, and each row names the sources that report it.

DrugChEMBL IDTypeOpen Targets' stageStage reported byReportsOf them trialsTrials shown hereSource
CALCITRIOLCHEMBL846Small moleculePhase 2ClinicalTrials.gov111Drugs and targets
ISOTRETINOINCHEMBL547Small moleculePhase 2ClinicalTrials.gov111Drugs and targets
ACETYLCARNITINECHEMBL1697733Small moleculeUnknownClinicalTrials.gov111Drugs and targets
ASCORBIC ACIDCHEMBL196Small moleculeUnknownClinicalTrials.gov110Drugs and targets
CARNITINECHEMBL172513Small moleculeUnknownClinicalTrials.gov110Drugs and targets
CITRIC ACIDCHEMBL1261Small moleculeUnknownClinicalTrials.gov111Drugs and targets
FOLIC ACIDCHEMBL1622Small moleculeUnknownClinicalTrials.gov111Drugs and targets
FRUCTOSECHEMBL1232863Small moleculeUnknownClinicalTrials.gov111Drugs and targets
LEVOCARNITINECHEMBL1149Small moleculeUnknownClinicalTrials.gov110Drugs and targets
SELENIUMCHEMBL6068503Small moleculeUnknownClinicalTrials.gov111Drugs and targets

1 to 10 of 14

See all 14 drugs

Targets4

The targets ChEMBL's mechanism records give for the disease's drugs, through Open Targets, the most drugs first. A mechanism record says what a drug acts on, not that the target causes the disease.

TargetProteinIts drugs that act on itMechanismsHighest stage of those drugsGene in GenesSource
RARARetinoic acid receptor1Retinoic acid receptor agonistPhase 2https://conductscience.org/library/genes/5914Drugs and targets
RARBRetinoic acid receptor1Retinoic acid receptor agonistPhase 2https://conductscience.org/library/genes/5915Drugs and targets
RARGRetinoic acid receptor1Retinoic acid receptor agonistPhase 2https://conductscience.org/library/genes/5916Drugs and targets
VDRVitamin D3 receptor1Vitamin D receptor agonistPhase 2https://conductscience.org/library/genes/7421Drugs and targets

Trials2

Trials an Open Targets clinical report links to the disease, posted results first, then the largest. A trial is shown when the release's checks confirm its link to the disease and Drugs and targets shows its link to one of the disease's drugs.

TrialTitlePhaseParticipantsResults first postedConditionsDrugsLinked bySource
NCT02061384RA-2 13-cis Retinoic Acid (Isotretinoin)Phase 2202021-07-30Male Infertility, Klinefelter's Syndrome, Y-chromosome MicrodeletionsCALCITRIOL, ISOTRETINOINIts record names the diseaseClinicalTrials.gov
NCT06042738Investigation of The Effectiveness of Antioxidant Therapy in Oligoasthenoteratozoospermic Infertile MenNot applicable48Male InfertilityACETYLCARNITINE, CITRIC ACID, FOLIC ACID, FRUCTOSE, SELENIUM, UBIDECARENONE, VITAMIN B12Its record names the diseaseClinicalTrials.gov

Comparisons in its trials2

Comparisons Trial comparisons calculated in the trials shown here, most participants first. A comparison in one of these trials does not always compare a treatment for the disease, so read the two groups.

ComparisonGroup 1, with the outcomeGroup 2, with the outcomeParticipantsTrialSource
13-cis Retinoic Acid + Oral Calcitriol vs 13-cis Retinoic Acid: deaths from any cause0 of 100 of 1020NCT02061384Trial comparisons
13-cis Retinoic Acid + Oral Calcitriol vs 13-cis Retinoic Acid: serious adverse events0 of 100 of 1020NCT02061384Trial comparisons

Papers from its trials1

The papers the trials shown here list on ClinicalTrials.gov as their results (RESULT) or as drawn from them (DERIVED), results first, newest first.

PMIDListed asTrials listing it
39536246DERIVED1

Source PubMed

Data dates

The date of each source this release read.

Open Targets
2026-09-18
Open Targets
Drug links and their checks, from Drugs and targets
2026-09-18
Drugs and targets
ClinicalTrials.gov, from Trials
2026-11-12
Trials
Comparisons, from Trial comparisons
2026-03-23
Trial comparisons
PubMed, for the checks
2026-11-06
PubMed
MeSH, for the checks
2026-11-10
MeSH

Sources 6

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • NLM's MeSHNLM's terms
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • NLM's MeSHNLM's
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this disease from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/diseases/v1/MONDO_0850098

GET https://conductscience.org/api/diseases/v1/MONDO_0850098/drugs